SPI Infoamtion

CHAPTER ONE: THE ANALYSIS OF GLOBAL CRO INDUSTRY MARKET
Section I The analysis of the development of CRO industry
•1. The sales scale of global pharmaceutical market (2009-2010)
•2. Top ten of global enterprises which invest into the research and development of new drugs (2007)
•3.Top fifteen of global enterprises which invest into the research and development (2008-2009)

Section II The analysis of the scales of global CRO markets
•1. The analysis of global R & D expenses on new drugs (2009-2012)
•2. The scale of global CRO market (2009-2012)
•3. The prospect of global R & D outsourcing of new drugs

Section III The analysis of CRO market structure in 2009
•1. The analysis of R & D outsourcing of new drugs
•2. The business structure of new drugs R & D outsourcing
•3. The characteristics of the business structure of new drugs R & D outsourcing service

Section IV The analysis of CRO local market in 2009
•1. The structure of global CRO market
•2. The analysis of American CRO industy
•3. The analysis of Indian CRO market
•4. The analysis of CRO market in Taiwan

Section V The structure of the competition between CRO enterprises in 2009
•1. The analysis of global CRO enterprises
•2. The scan of the world' s top CRO companies

CHAPTER: TWO THE ANALYSIS OF CHINESE CRO MARKET
Section I The analysis of the development of Chinese CRO
•1. The development of CRO in China
•2. The prospects of CRO in China

Section II The analysis of domestic CRO market
•1. Chinese CRO market between 2006 and 2009
•2. The analysis of the business structure of domestic enterprises

Section III The competition structure of domestic CRO market
•1. The types of the characteristics of domestic CRO enterprises
•2. The types of the business of domestic CRO enterprises
•3. The domestic CRO companies
•4. Zhongguancun biomedical R & D outsourcing Union (CRO)
•5.The biomedical R & D outsourcing center in Shanghai Pudong New Area

Section V The latest trends of the industry between 2009 and 2010
•1. NovaMed completes financing the second round of venture capital
•2. Sundia completes financing the second round venture capital in January of 2010
•3. NovaSecta joins Chinese pharmaceutical R & D outsourcing company Union for the first time

CHAPTER TREE: THE ANALYSIS OF DOMESTIC KEY ENTERPRISES
Section I Pharma Tech
•1. The introduction of the enterprise
•2. The SWOT analysis of competitiveness
•3. The analysis of the financial operation in 2009

Section II The analysis of other enterprises
•1. Shanghai Chempartner Co. Ltd.
•2. Sandia medical technology (Shanghai)
•3. Beijing MDS
•4. Beijing KendleWits Medicine
•5. Beijing Excel Medical Technology Development Co. Ltd.
•6. Beijing Venturepharm Technology Co., Ltd.
•7. Guangzhou Bo Ji State new drugs clinical research center
•8. PHARMARON (Beijing) new drugs Technology Co., Ltd.
Notice
Index of Charts

TABLES:
•TABLE 1. TOP TEN OF GLOBAL ENTERPRISES WHICH INVEST INTO R & D OF NEW DRUGS (2007)
•TABLE 2. THE TREND OF GLOBAL ENTERPRISES WHICH INVEST INTO R & D (2008-2009)
•TABLE 3. THE MARKET GROWTH OF CRO OF GLOBAL PHARMACEUTICAL INDUSTRIES (UNIT: 100 MILLION U.S. DOLLARS)
•TABLE 4. THE GLOBAL CRO MARKET SHARE (UNIT: 100 MILLION U.S. DOLLARS; %)
•TABLE 5. THE SALES VOLUME OF GLOBALLY KEY CRO ENTERPRISES IN 2009
•TABLE 6. MAIN GLOBAL CRO INSTITUTES AND THEIR BUSINESS DIRECTIONS
•TABLE 7. THE LIST OF PART OF DOMESTIC CRO ENTERPRISES
•TABLE 8. SPONSORS OF ZHONGGUANCUN BIOMEDICAL R & D OUTSOURCING UNION (ALL IN RANDOM ORDER)
•TABLE 9. PART OF ENTERPRISES ENGAGING IN BIOMEDICAL R & D OUTSOURCING SERVICE IN SHANGHAI PUDONG NEW AREA
•TABLE 10. THE SWOT ANALYSIS OF PHARMATECH
•TABLE 11. THE PROJECTS COMPLETED BY VPS
•TABLE 12. THE PROJECTS WHICH ARE BEING OPERATED BY VPS

FIGURES:
•FIGURE 1. THE TREND OF THE GLOBAL CRO MARKET (2009-2012)
•FIGURE 2. THE SCALE MAP OF THE OUTSOURCING MARKET VALUE OF NEW DRUGS R & D IN 2009
•FIGURE 3. THE SCALE MAP OF THE OUTSOURCING MARKET VALUE OF NEW DRUGS R & D
•FIGURE 4. THE MARKET SHARE OF GLOBAL LEADING INTERNATIONAL CRO SECTORS (2003)
•FIGURE 5. THE TREND OF CHINESE CRO MARKET BETWEEN 2006 AND 2009(UNIT: HUNDRED MILLION YUAN)
•FIGURE 6. THE REVENUE CHANGE OF (UNIT: MILLION DOLLARS)
•FIGURE 7. THE REGIONAL RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN 2009
•FIGURE 8. THE RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN TERMS OF DIFFERENT CUSTOMES IN 2009
•FIGURE 9. THE RATIO OF THE REVENUE OF MDS PHARMA RESEARCH CO. IN TERMS OF DIFFERENT BUSINESS STRUCTURES IN 2009